✦ LIBER ✦

Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts

✍ Scribed by Nicoletti, M.I.; Lucchini, V.; D'Incalci, M.; Giavazzi, R.

Book ID: 123404924
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 783 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90547-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of paclitaxel liposome formulat

Activity of paclitaxel liposome formulations against human ovarian tumor xenografts

✍ Amarnath Sharma; Eric Mayhew; Lois Bolcsak; C. Cavanaugh; P. Harmon; Andrew Jano 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

Although the current clinical formulation of paclitaxel (Taxolt) is an important new anti-cancer agent, it has significant side effects, some of which are related to its formulation in Cremophor/ethanol. Paclitaxel is difficult to formulate for i.v. administration because of its poor aqueous solubil

The Effects of Vandetanib on Paclitaxel

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma

✍ Cesca, Marta; Frapolli, Roberta; Berndt, Alexander; Scarlato, Valentina; Richter 📂 Article 📅 2009 🏛 Neoplasia Press 🌐 English ⚖ 782 KB

Antitumor activity of paclitaxel against

Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice

✍ Kubota, Tetsuro; Matsuzaki, Shinjiro Wilson; Hoshiya, Yasunori; Watanabe, Masahi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Background: Paclitaxel (BMS-181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of paclitaxel was evaluated using five human breast carcinoma xenografts in nude mice. Methods: Paclitaxel at 20 mg/kg dissolved in 0.2 ml ethanol/cremophor EL solution wa

Comparison of antiangiogenic activities

Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)

✍ Derrick S. Grant; Torian L. Williams; Michael Zahaczewsky; Adam P. Dicker 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 955 KB

## Abstract Tumor growth requires a competent vascular supply and angiogenesis has been considered as a potential target for the treatment of several cancers. The two clinically approved taxanes, paclitaxel and docetaxel, are novel antimitotic agents that are under extensive investigation in clinic

119 POSTER The effects of treatment sequ

119 POSTER The effects of treatment sequencing on the antitumor activity of vandetanib and paclitaxel in a model of ovarian carcinoma xenograft

✍ M. Cesca; R. Frapolli; S. Scarlato; A.J. Ryan; E. Bello; R. Giavazzi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Glucocorticoids interfere with therapeut

Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors

✍ Meihua Sui; Feng Chen; Zhi Chen; Weimin Fan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 901 KB

## Abstract Paclitaxel is a widely used naturally occurring antineoplastic agent that has shown great promise in the treatment of a variety of human solid tumors, particularly for advanced breast and ovarian cancers. Recent studies in our laboratory discovered that glucocorticoids could selectively